News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
870,474 Results
Type
Article (88013)
Company Profile (825)
Press Release (781616)
Multimedia
Podcasts (197)
Webinars (28)
Section
Business (233286)
Career Advice (4147)
Deals (39884)
Drug Delivery (151)
Drug Development (91429)
Employer Resources (205)
FDA (18399)
Job Trends (17428)
News (397961)
Policy (39972)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3012)
Academic (2)
Accelerated approval (34)
Adcomms (36)
Allergies (148)
Alliances (56982)
ALS (181)
Alzheimer's disease (1795)
Antibody-drug conjugate (ADC) (348)
Approvals (18576)
Artificial intelligence (632)
Autoimmune disease (166)
Automation (38)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (203)
Biotechnology (490)
Bladder cancer (163)
Brain cancer (65)
Breast cancer (668)
Cancer (5065)
Cardiovascular disease (448)
Career advice (3570)
Career pathing (41)
CAR-T (305)
CDC (59)
Celiac Disease (2)
Cell therapy (833)
Cervical cancer (37)
Clinical research (77061)
Collaboration (1833)
Company closure (5)
Compensation (1167)
Complete response letters (73)
COVID-19 (2994)
CRISPR (99)
C-suite (873)
Cystic fibrosis (154)
Data (6295)
Decentralized trials (2)
Denatured (72)
Depression (151)
Diabetes (535)
Diagnostics (7237)
Digital health (48)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (304)
Drug pricing (225)
Drug shortages (36)
Duchenne muscular dystrophy (239)
Earnings (100177)
Editorial (64)
Employer branding (25)
Employer resources (173)
Events (135107)
Executive appointments (1033)
FDA (21600)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1560)
Gene editing (216)
Generative AI (67)
Gene therapy (676)
GLP-1 (1136)
Government (5446)
Grass and pollen (8)
Guidances (386)
Healthcare (20948)
HIV (63)
Huntington's disease (49)
IgA nephropathy (86)
Immunology and inflammation (293)
Immuno-oncology (60)
Indications (100)
Infectious disease (3282)
Inflammatory bowel disease (206)
Inflation Reduction Act (17)
Influenza (120)
Intellectual property (249)
Interviews (816)
IPO (17958)
IRA (60)
Job creations (5200)
Job search strategy (2866)
JPM (70)
Kidney cancer (17)
Labor market (93)
Layoffs (660)
Leadership (40)
Legal (10160)
Liver cancer (99)
Longevity (16)
Lung cancer (681)
Lymphoma (380)
Machine learning (45)
Management (66)
Manufacturing (860)
MASH (175)
Medical device (15035)
Medtech (15089)
Mergers & acquisitions (22995)
Metabolic disorders (1410)
Multiple sclerosis (164)
NASH (23)
Neurodegenerative disease (356)
Neuropsychiatric disorders (101)
Neuroscience (3124)
Neurotech (1)
NextGen: Class of 2026 (7708)
Non-profit (5112)
Now hiring (66)
Obesity (684)
Opinion (336)
Ovarian cancer (167)
Pain (214)
Pancreatic cancer (231)
Parkinson's disease (301)
Partnered (39)
Patents (512)
Patient recruitment (489)
Peanut (60)
People (66932)
Pharmaceutical (145)
Pharmacy benefit managers (33)
Phase 1 (23810)
Phase 2 (33439)
Phase 3 (25197)
Pipeline (5148)
Policy (339)
Postmarket research (3554)
Preclinical (10694)
Press Release (72)
Prostate cancer (249)
Psychedelics (56)
Radiopharmaceuticals (301)
Rare diseases (915)
Real estate (7440)
Recruiting (80)
Regulatory (29056)
Reports (67)
Research institute (2727)
Resumes & cover letters (651)
Rett syndrome (28)
RNA editing (20)
RSV (84)
Schizophrenia (159)
Series A (258)
Series B (197)
Service/supplier (30)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (177)
Sponsored (48)
Startups (4333)
State (2)
Stomach cancer (20)
Supply chain (113)
Tariffs (101)
The Weekly (123)
Vaccines (1151)
Venture capital (97)
Weight loss (472)
Women's health (89)
Worklife (21)
Date
Today (119)
Last 7 days (569)
Last 30 days (2597)
Last 365 days (32822)
2026 (2785)
2025 (33230)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (91)
Alaska (7)
Arizona (343)
Arkansas (14)
Asia (51575)
Australia (9060)
California (11583)
Canada (3326)
China (1175)
Colorado (491)
Connecticut (502)
Delaware (350)
Europe (118496)
Florida (1696)
Georgia (374)
Hawaii (4)
Idaho (68)
Illinois (968)
India (69)
Indiana (545)
Iowa (24)
Japan (431)
Kansas (133)
Kentucky (43)
Louisiana (29)
Maine (83)
Maryland (1461)
Massachusetts (8520)
Michigan (361)
Minnesota (667)
Mississippi (6)
Missouri (139)
Montana (35)
Nebraska (29)
Nevada (126)
New Hampshire (86)
New Jersey (3117)
New Mexico (33)
New York (3061)
North Carolina (1614)
North Dakota (10)
Northern California (5545)
Ohio (354)
Oklahoma (22)
Oregon (55)
Pennsylvania (2314)
Puerto Rico (23)
Rhode Island (50)
South America (1663)
South Carolina (65)
South Dakota (1)
Southern California (4471)
Tennessee (177)
Texas (1827)
United States (41788)
Utah (347)
Vermont (1)
Virginia (292)
Washington D.C. (88)
Washington State (976)
West Virginia (4)
Wisconsin (130)
Wyoming (2)
There are 870,474 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Novo’s Wegovy Pill Success Is ‘Good News’ for Orforglipron, Lilly Execs Say
Novo Nordisk and Eli Lilly both think the Wegovy pill is doing well, but the American rival sees the successful launch as a harbinger of good news for its own candidate, orforglipron, which is expected to hit the market in the second quarter.
February 4, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
OS Therapies Applauds Reauthorization of Pediatric Priority Review Voucher Program to Advance Breakthrough Osteosarcoma Immunotherapies
February 4, 2026
·
5 min read
Press Releases
Lightship Inc. Acquires Veda Trials to Expand Community-Based Clinical Research Delivery[BK1]
The acquisition expands scalable trial operations across real-world care settings
February 4, 2026
·
1 min read
Events
Medical Affairs and Scientific Communications Forum
DIA’s Medical Affairs and Scientific Communications Forum brings together medical affairs professionals to share best practices, tackle current challenges, and drive innovation in healthcare communication. What to Expect: Three specialized tracks: medical communications, medical writing, and field medical Roundtable discussions and real-world case studies you can apply immediately Poster sessions featuring original research DIA Community Meet-ups and networking receptions Exhibit hall showcasing innovative technologies and solutions Why Attend: Connect with like-minded professionals, gain practical insights on regulatory compliance and strategic communications, and build cross-functional relationships that enhance your impact. Designed by medical affairs practitioners, for practitioners.
February 4, 2026
Earnings
AbbVie’s I&I Portfolio Sells $30 Billion but Execs Again Underline Other Areas
On its fourth quarter earnings call Wednesday, AbbVie CEO Robert Michael called oncology and neuroscience “underappreciated” areas of focus for the pharma.
February 4, 2026
·
2 min read
·
Dan Samorodnitsky
Press Releases
Proscia Named Global 2026 Best in KLAS for Digital Pathology in Europe 100% of customers interviewed would buy again, citing trust for primary diagnosis at scale and a partnership they can count on
February 4, 2026
·
1 min read
Earnings
Novo Goes ‘All In’ on Wegovy Pill but Analysts Worry It’s Not Enough
Novo Nordisk CEO Maziar Mike Doustdar acknowledged the market pressure facing the company’s GLP-1 products but sought to assure investors that Novo has the situation under control.
February 4, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Medexus Schedules Third Fiscal Quarter 2026 Conference Call
February 4, 2026
·
3 min read
Press Releases
Defence Therapeutics to Present at the World ADC Europe 2026 Showcasing Accum Precision Intracellular Drug-Delivery Platform
February 4, 2026
·
4 min read
Press Releases
Theralase(R) Provides Update on Bladder Cancer Clinical Study
Interim clinical data has exceeded the recommended guidelines of the International Bladder Cancer Group for complete response and duration of complete response
February 4, 2026
·
7 min read
1 of 87,048
Next
